ETNMX
Price
$15.02
Change
+$0.10 (+0.67%)
Updated
Sep 11 closing price
Net Assets
376.53M
RLBAX
Price
$39.98
Change
+$0.10 (+0.25%)
Updated
Sep 11 closing price
Net Assets
284.75B
Interact to see
Advertisement

ETNMX vs RLBAX

ETNMX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
ETNMX vs. RLBAX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNMX is a Hold and RLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 285B vs. ETNMX (377M). ETNMX pays higher dividends than RLBAX: ETNMX (1.82) vs RLBAX (1.12). ETNMX was incepted earlier than RLBAX: ETNMX (11 years) vs RLBAX (24 years). RLBAX (1.32) is less costly to investors than ETNMX (1.02). ETNMX is a more actively managed with annual turnover of: 55.00 vs. RLBAX (50.00). RLBAX has a lower initial minimum investment than ETNMX: RLBAX (250) vs ETNMX (1000). RLBAX annual gain was more profitable for investors over the last year : 5.83 vs. ETNMX (0.91). RLBAX return over 5 years is better than : 27.39 vs. ETNMX (12.05).
ETNMXRLBAXETNMX / RLBAX
Total Expense Ratio1.021.3277%
Annual Report Gross Expense Ratio1.021.3277%
Fund Existence11 years24 years-
Gain YTD5.9617.93575%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets377M285B0%
Annual Yield % from dividends1.821.12163%
Returns for 1 year0.915.8316%
Returns for 3 years25.7238.2167%
Returns for 5 years12.0527.3944%
Returns for 10 years73.2975.0098%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR3.920.07
+1.82%
Larimar Therapeutics
EGP198.121.42
+0.72%
EastGroup Properties
RAPP43.620.16
+0.37%
Rapport Therapeutics Inc.
MLAAU10.08N/A
N/A
Mountain Lake Acquisition Corp II
HRTX0.32-0.01
-2.11%
Heron Therapeutics